A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint

被引:17
作者
Bever, Katherine M. [1 ]
Thomas, Dwayne L., II [1 ,2 ]
Zhang, Jiajia [1 ]
Rivera, Ernie A. Diaz [1 ]
Rosner, Gary L. [3 ]
Zhu, Qingfeng [1 ]
Nauroth, Julie M. [1 ]
Christmas, Brian [1 ]
Thompson, Elizabeth D. [1 ,2 ]
Anders, Robert A. [2 ]
Judkins, Carol [1 ]
Liu, Meizheng [1 ]
Jaffee, Elizabeth M. [1 ]
Ahuja, Nita [1 ,4 ,5 ,6 ,7 ]
Zheng, Lei [1 ,4 ]
Azad, Nilofer S. [1 ]
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Bloomberg Kimmel Inst Canc Immunotherapy, Dept Oncol,Sch Med, 1650 Orleans St,Off 4M10, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Div Biostat & Bioinformat, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[5] Yale Univ, Sch Med, Dept Surg, Smilow Comprehens Canc Ctr, New Haven, CT 06510 USA
[6] Yale Univ, Sch Med, Smilow Comprehens Canc Ctr, Dept Oncol, New Haven, CT USA
[7] Yale Univ, Sch Med, Dept Pathol, Smilow Comprehens Canc Ctr, New Haven, CT 06510 USA
关键词
GVAX; Immunotherapy; Epigenetic therapy; Colorectal cancer;
D O I
10.1186/s13148-021-01014-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetic therapies may modulate the tumor microenvironment. We evaluated the safety and optimal sequence of combination DNA methyltransferase inhibitor guadecitabine with a granulocyte macrophage-colony-stimulating-factor (GM-CSF) secreting colon cancer (CRC) vaccine (GVAX) using a primary endpoint of change in CD45RO+T cells. 18 patients with advanced CRC enrolled, 11 underwent paired biopsies and were evaluable for the primary endpoint. No significant increase in CD45RO+cells was noted. Grade 3-4 toxicities were expected and manageable. Guadecitabine+GVAX was tolerable but demonstrated no significant immunologic activity in CRC. We report a novel trial design to efficiently evaluate investigational therapies with a primary pharmacodynamic endpoint.Trial registry Clinicaltrials.gov: NCT01966289. Registered 21 October, 2013.
引用
收藏
页数:9
相关论文
共 39 条
[1]   Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat; a phase 2 consortium/stand Up 2 cancer study [J].
Azad, Nilofer S. ;
el-Khoueiry, Anthony ;
Yin, Jun ;
Oberg, Ann L. ;
Flynn, Patrick ;
Adkins, Douglas ;
Sharma, Anup ;
Weisenberger, Daniel J. ;
Brown, Thomas ;
Medvari, Prakriti ;
Jones, Peter A. ;
Easwaran, Hariharan ;
Kamel, Ihab ;
Bahary, Nathan ;
Kim, George ;
Picus, Joel ;
Pitot, Henry C. ;
Erlichman, Charles ;
Donehower, Ross ;
Shen, Hui ;
Laird, Peter W. ;
Piekarz, Richard ;
Baylin, Stephen ;
Ahuja, Nita .
ONCOTARGET, 2017, 8 (21) :35326-35338
[2]   Inhibiting DNA Methylation by 5-Aza-2′-deoxycytidine Ameliorates Atherosclerosis Through Suppressing Macrophage Inflammation [J].
Cao, Qiang ;
Wang, Xianfeng ;
Jia, Lin ;
Mondal, Ashis K. ;
Diallo, Abdoulaye ;
Hawkins, Gregory A. ;
Das, Swapan K. ;
Parks, John S. ;
Yu, Liqing ;
Shi, Huidong ;
Shi, Hang ;
Xue, Bingzhong .
ENDOCRINOLOGY, 2014, 155 (12) :4925-4938
[3]   Combining Epigenetic and Immunotherapy to Combat Cancer [J].
Chiappinelli, Katherine B. ;
Zahnow, Cynthia A. ;
Ahuja, Nita ;
Baylin, Stephen B. .
CANCER RESEARCH, 2016, 76 (07) :1683-1689
[4]   Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into CheckpointResponsive Tumors by Reprogramming Tumor-Infiltrating MDSCs [J].
Christmas, Brian J. ;
Rafie, Christine I. ;
Hopkins, Alexander C. ;
Scott, Blake A. ;
Ma, Hayley S. ;
Cruz, Kayla A. ;
Woolman, Skylar ;
Armstrong, Todd D. ;
Connolly, Roisin M. ;
Azad, Nilo A. ;
Jaffee, Elizabeth M. ;
Torres, Evanthia T. Roussos .
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (12) :1561-1577
[5]   Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study [J].
Connolly, Roisin M. ;
Li, Huili ;
Jankowitz, Rachel C. ;
Zhang, Zhe ;
Rudek, Michelle A. ;
Jeter, Stacie C. ;
Slater, Shannon A. ;
Powers, Penny ;
Wolff, Antonio C. ;
Fetting, John H. ;
Brufsky, Adam ;
Piekarz, Richard ;
Ahuja, Nita ;
Laird, Peter W. ;
Shen, Hui ;
Weisenberger, Daniel J. ;
Cope, Leslie ;
Herman, James G. ;
Somlo, George ;
Garcia, Agustin A. ;
Jones, Peter A. ;
Baylin, Stephen B. ;
Davidson, Nancy E. ;
Zahnow, Cynthia A. ;
Stearns, Vered .
CLINICAL CANCER RESEARCH, 2017, 23 (11) :2691-2701
[6]   Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide [J].
Coral, Sandra ;
Parisi, Giulia ;
Nicolay, Hugues J. M. G. ;
Colizzi, Francesca ;
Danielli, Riccardo ;
Fratta, Elisabetta ;
Covre, Alessia ;
Taverna, Pietro ;
Sigalotti, Luca ;
Maio, Michele .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (03) :605-614
[7]  
de Groot Amber E, 2018, Oncotarget, V9, P20908, DOI 10.18632/oncotarget.24556
[8]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[9]   Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2′-deoxycytidine in cutaneous melanoma:: Immunotherapeutic implications [J].
Fonsatti, Ester ;
Nicolay, Hugues J. M. ;
Sigalotti, Luca ;
Calabro, Luana ;
Pezzani, Laura ;
Colizzi, Francesca ;
Altomonte, Maresa ;
Guidoboni, Massimo ;
Marincola, Francesco M. ;
Maio, Michele .
CLINICAL CANCER RESEARCH, 2007, 13 (11) :3333-3338
[10]   Type, density, and location of immune cells within human colorectal tumors predict clinical outcome [J].
Galon, Jerom ;
Costes, Anne ;
Sanchez-Cabo, Fatima ;
Kirilovsky, Amos ;
Mlecnik, Bernhard ;
Lagorce-Pages, Christine ;
Tosolini, Marie ;
Camus, Matthieu ;
Berger, Anne ;
Wind, Philippe ;
Zinzindohoue, Franck ;
Bruneval, Patrick ;
Cugnenc, Paul-Henri ;
Trajanoski, Zlatko ;
Fridman, Wolf-Herman ;
Pages, Franck .
SCIENCE, 2006, 313 (5795) :1960-1964